Document:

Exhibit 10.9.1 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

 

This FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
(this “Amendment”) is made as of June 13, 2014 by and between Microlin Bio, Inc., a Delaware corporation with
its principal business address at 135 East 57th St., 12th Floor, New York, NY 10022 (the “Company”), and Joseph
Hernandez, an individual residing at 635 West 42nd Street Apt. 11K (the “Executive”).

 

WHEREAS, the Company and the Executive are
parties to that certain Employment Agreement, dated as of July 15, 2013 (the “Agreement”); and

 

WHEREAS, the Company and the Executive desire
to amend and modify the Employment Agreement.

 

NOW, THEREFORE, in consideration of the
mutual promises hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:

 

1.                 
Defined Terms. Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms
in the Agreement.

 

2.                 
Amendment to Compensation. Section 4.1 of the Agreement is hereby amended by deleting Section 4.1 in its entirety
and inserting in place thereof the following:

 

4.1 Salary. The Company shall pay the
Executive an annual salary of $460,000, to be paid in accordance with the Company’s payroll practices commencing immediately
at the Commencement Date and continuing until the closing of the Company’s initial public offering of shares of its common
stock (the “Initial Public Offering”). Effective immediately upon the closing of the Initial Public Offering,
the Executive’s annual salary shall be reduced to $395,000, to be paid in accordance with the Company’s payroll practices
and continuing for the duration of the Employment Period. Such salary as then in effect is referred to in the Agreement as “Annual
Salary.” The Executive shall be subject to Annual Salary review by the Board.

 

3.                 
Continuing Effect; No Other Amendments. Except as expressly amended hereby, all of the terms and provisions of the
Agreement are and shall remain in full force and effect. Each reference that is made in the Agreement shall hereafter be construed
as a reference to the Agreement as amended hereby.

 

4.                 
Further Assurances. Each of the parties hereto shall, from time to time at the request of the other party, furnish
the other party such further information or assurances, execute and deliver such additional documents, instruments and conveyances,
and take such other actions and do such other things, as may be necessary to carry out the provisions of this Amendment and give
effect to the transactions contemplated hereby.

 

5.                 
Miscellaneous.

 

 

(a)               
Binding Effect. This Amendment will be binding upon and inure to the benefit of both parties and their respective
successors and assigns.

 

(b)              
Entire Agreement; Amendments. This Amendment constitutes the entire agreement between the parties and supersedes
all prior agreements and understandings, whether written or oral, relating to the subject matter hereof. This Amendment
may not be amended orally but only by a written agreement signed by the Company and the Executive.

 

    	 

    	 

    

 

(c)               
Governing Law. This Amendment shall be construed, interpreted and enforced in accordance with the laws of the State
of New York, without regard to its conflicts of laws principles.

 

(d)              
Counterparts. This Amendment may be executed in two counterparts, each of which will be deemed an original, but all
of which together will constitute but one and the same instrument.

 

[signature page follows]

    	 

    	 

    

 

 

IN WITNESS WHEREOF, the parties hereto have
executed this Amendment as of the date and year first set forth above.

	 	MICROLIN BIO, INC.
	 	 
	 	By: 	/s/ Joseph Hernandez
	 	 	Joseph Hernandez
Executive Chairman

 

	 	EXECUTIVE
	 	 
	 	By: 	/s/ Joseph Hernandez
	 	 	Joseph HernandezExhibit 10.26

June 13, 2014

Microlin Bio, Inc.

135 E. 57th St., 12th Floor

New York, NY 10022

 

Re:  Voting Restrictions on Shares in Excess of 20% Held
by Mr. Joseph Hernandez

 

Ladies and Gentlemen:

 

In this letter entered
into as of the date set forth above (this “Agreement”), Joseph Hernandez (“Hernandez”) agrees that following
the consummation of the initial public offering (the “IPO”) of Microlin Bio, Inc. (the “Company”), he shall,
in connection with any matters presented to the Company’s stockholders for vote or action by written consent, vote or provide
any consent, with respect to any shares of the Company’s common stock either directly or indirectly beneficially held by
him (currently held or hereafter acquired and including any shares held by any trust or another entity as to which Hernandez is
deemed to have beneficial ownership under federal securities laws), which are in excess of 20% of the Company’s then-outstanding
common stock (such shares in excess of 20% of the Company’s then-outstanding common stock (calculated at the time of voting
or providing consents on each matter presented to stockholders), “Hernandez’s Shares”), in the same proportion
as the votes cast, or consents provided, by all other stockholders of the Company (excluding Hernandez).

 

Except as set forth in
the immediately following paragraph, Hernandez hereby irrevocably grants to, and appoints, the Company, and any individual designated
in writing by the Company and determined by the majority of the independent directors then in office, and each of them individually,
as Hernandez’s proxy and attorney-in-fact (with full power of substitution and resubstitution), for and in his name, place
and stead, to vote Hernandez’s Shares at any stockholder meeting and in connection with any stockholder action taken by written
consent. Except as otherwise provided herein, Hernandez hereby (i) affirms that the irrevocable proxy is coupled with an interest
and may under no circumstances be revoked, (ii) ratifies and confirms all that the proxies appointed hereunder may lawfully do
or cause to be done by virtue hereof, and (iii) affirms that such irrevocable proxy is intended to be irrevocable in accordance
with the provisions of Section 212(e) of the General Corporation Law of the State of Delaware (“DGCL”). Notwithstanding
any other provisions of this Agreement, the irrevocable proxy granted hereunder shall automatically terminate upon the termination
of this Agreement.

 

The foregoing restrictions
on Mr. Hernandez’s voting control shall not apply in the event that (i) an alternative slate of directors is proposed at
any meeting of stockholders or other contested election in which Mr. Hernandez is nominated by the Company for election as a director,
(ii) any action is brought to a vote of stockholders to remove Mr. Hernandez as a director or as CEO of the Company, other than
for cause, or (iii) any written consent for a purpose similar to (i) or (ii), in which cases Mr. Hernandez may vote or provide
consents with respect to Hernandez’s Shares on any matter in any manner as he so wishes.

 

This Agreement shall
terminate on the first anniversary following the date of this Agreement.

 

Hernandez hereby acknowledges
and agrees that if he votes, or provides consents, in any manner that breaches this Agreement, the Company, in the determination
of the majority of independent directors then in office, has the right to disregard his voting directions and, instead, count his
votes, or consents, as applicable, as if he voted as directed in this Agreement. Hernandez further agrees not to bring any action
against the Company seeking to enforce recognition of his votes in any manner other than as directed in this Agreement. Hernandez
further indemnifies the Company to the full extent permitted by law for any action arising under this Agreement, including payment
of attorney’s fees.

    	 

    	 

    

 

Hernandez hereby represents
that he has the legal capacity and all requisite power and authority to enter into and perform all of his obligations under this
Agreement. This Agreement has been duly and validly executed and delivered by Hernandez and constitutes his valid and binding obligation
enforceable against him in accordance with its terms. Except as expressly contemplated hereby, Hernandez is not a party to, and
Hernandez’s Shares are not subject to or bound in any manner by, any contract or agreement relating to Hernandez’s
Shares, including without limitation, any proxy, voting agreement, option agreement, purchase agreement, stockholders’ agreement,
partnership agreement or voting trust.

 

The Company shall in
good faith assist Hernandez in carrying out his obligations under this Agreement. None of the provisions of this Agreement shall
apply to any transferee of Hernandez’s Shares that is not Hernandez’s affiliate. This Agreement shall not be amended
and no provision hereof shall be waived without the written consent of the parties hereto; provided that the Company’s consent
to any amendment or waiver of any provision hereof shall require the approval of the majority of independent directors then in
office.

 

This Agreement shall
be governed by and construed in accordance with the laws of the State of Delaware without regard to the principles of conflicts
of law thereof. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together
shall constitute one and the same instrument.

 

Kindly indicate your agreement to the foregoing by signing in the space provided below.

 

	 	

Sincerely,

	 	 
	 	By: 	/s/ Joseph Hernandez
	 	 	JOSEPH HERNANDEZ

Accepted and agreed to as of

the date first written above:

 

MICROLIN BIO, INC.

 

 

	 	 
	By: 	/s/ Joseph Hernandez	 
	 	Name: Joseph Hernandez

	 
	 	Title: Executive Chairman and Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]